DGCI cancels license of 18 pharma firms, months after cough syrup deaths

The decision by the DGCA was taken after it examined 76 enterprises across 20 states and union territories, with close to 203 firms being identified for review.

Related Keywords

Madhya Pradesh ,India ,Athens ,Attikír ,Greece ,Haryana ,Gambia ,Uttarakhand ,Uttaranchal ,Himachal ,Uzbekistan ,Himachal Pradesh ,Anrose Pharma ,Balaji Pharmatech ,Madhya Pradesh Nestor Pharmaceuticals ,Gnosis Pharmaceuticals Private ,Athens Life Sciences ,Shri Ramesh Industries ,Laborate Pharmaceuticals India ,Medica Lab ,Trugen Pharmaceuticals ,Rhydburg Pharmaceuticals ,Alliance Biotech ,Park Pharmaceuticals ,Eg Pharmaceuticals ,Lifesciences India ,Skymap Pharmaceuticals ,Vintochem Pharmaceuticals ,Life Sciences ,Amscot Health Series ,Drug Controller General ,Good Manufacturing Practice ,Himalaya Meditek ,Cure Healthcare ,Shri Sai Balaji Pharmatech ,Medipol Pharmaceutical India ,Zim Laboratories ,Nestor Pharmaceuticals ,Sun Aj Pharma ,Relief Biotech ,Apple Formulations ,Bajaj Formulations ,Agron Remedies ,Zee Laboratories ,India Limited ,Dgci ,Pharma ,Pharmaceuticals ,